Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients

about

Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients

Item

http://www.wikidata.org/entity/Q40982235

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients

@en

type

Item

label

Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients

@en

prefLabel

Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients

@en

P1476

Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients

@en

P2093

Agnieszka Namysł Kaletka

http://www.w3.org/2001/XMLSchema#string

Andrzej Tukiendorf

http://www.w3.org/2001/XMLSchema#string

Grzegorz Głowacki

http://www.w3.org/2001/XMLSchema#string

Grzegorz Woźniak

http://www.w3.org/2001/XMLSchema#string

Leszek Miszczyk

http://www.w3.org/2001/XMLSchema#string

Małgorzata Stąpór Fudzińska

http://www.w3.org/2001/XMLSchema#string

P2860

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer.

Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines.

Proctitis following stereotactic body radiation therapy for prostate cancer

Multi-institutional registry for prostate cancer radiosurgery: a prospective observational clinical trial.

Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?

Stereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma.

Prostate-specific antigen kinetics after primary stereotactic body radiation therapy using CyberKnife for localized prostate cancer.

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

P304

1007-1013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.22034/APJCP.2017.18.4.1007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aleksandra Napieralska

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28545199

http://www.w3.org/2001/XMLSchema#string

P932

5494208

http://www.w3.org/2001/XMLSchema#string